PaxMedica Operating Income

The latest operating income for PXMD is $-15M as of June 2024. That compares with $-15M in the prior-year period — down 2.5% year over year. Investors often review this figure alongside PaxMedica's historical trend and sector peers before judging valuation or financial health.

Over the past year, PXMD's operating income moved from $-15M to $-15M — a 2.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PaxMedica's operating scale or balance-sheet position.

A operating income figure of $-15M for PXMD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PXMD's operating income ($-15M), review year-over-year change from $-15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.